Lipiodol-induced Pneumonitis Following Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma

Bibliographic Details
Main Author:	Heechul Nam
Format:	Article
Language:	English
Published:	Jin Publishing & Printing Co. 2022-11-01
Series:	The Korean Journal of Gastroenterology
Online Access:	https://www.kjg.or.kr/journal/view.html?uid=5871&vmd=Full

Hepatogastric Fistula following Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma
by: Inderpreet Grover, et al.
Published: (2014-10-01)

Efficacy of Combined Therapy with Drug-Eluting Beads-Transcatheter Arterial Chemoembolization Followed by Conventional Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Multi-Center Study
by: Asahiro Morishita, et al.
Published: (2021-09-01)

Transhepatectomy combined with arterial chemoembolization and transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a clinical prognostic analysis
by: Xin Liu, et al.
Published: (2023-09-01)

Transcatheter arterial chemoembolization after stopping sorafenib therapy for advanced hepatocellular carcinoma.
by: Yao-Kuang Huang, et al.
Published: (2017-01-01)

I-125 seeds brachytherapy with transcatheter arterial chemoembolization for subcapsular hepatocellular carcinoma
by: Fu-Lei Gao, et al.
Published: (2022-06-01)

TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION IN THE TREATMENT OF PATIENTS WITH HEPATOCELLULAR CARCINOMA ON ADVANCED LIVER CIRRHOSIS
by: A. S. Polekhin, et al.
Published: (2020-03-01)

Value of computed tomography-based lipiodol retention pattern in the assessment of hepatocellular carcinoma complete response following conventional transarterial chemoembolization
by: Enas M. Sweed, et al.
Published: (2024-01-01)

Correlation between Arterial Enhancement Fraction on CT and Efficacy of Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma
by: Na GONG, et al.
Published: (2023-01-01)

Efficacy of rechallenge transcatheter arterial chemoembolization after lenvatinib treatment for advanced hepatocellular carcinoma
by: Sawako Uchida‐Kobayashi, et al.
Published: (2022-11-01)

Durable complete response is achieved by balloon‐occluded transcatheter arterial chemoembolization for hepatocellular carcinoma
by: Tomotake Shirono, et al.
Published: (2022-09-01)

Transcatheter arterial chemoembolization of hepatocellular carcinoma on liver cirrhosis in patients awaiting liver transplantation
by: A. S. Polekhin, et al.
Published: (2021-04-01)

Multifunctional nanoplatforms application in the transcatheter chemoembolization against hepatocellular carcinoma
by: Gang Yuan, et al.
Published: (2023-02-01)

Development of a predictive nomogram for postembolization syndrome after transcatheter arterial chemoembolization of hepatocellular carcinoma
by: Jinfeng Bai, et al.
Published: (2024-02-01)

Local Recurrence following Radiological Complete Response in Patients Treated with Subsegmental Balloon-Occluded Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma
by: Dong Il Gwon, et al.
Published: (2023-10-01)

Lipiodol accumulation pattern as imaging biomarker of tumoral response after conventional transarterial chemoembolization and survival outcome in hepatocellular carcinoma patients
by: Azizi, Mohd Yadie Syazwan
Published: (2021)

Role of triphasic computed tomography in prediction of response to transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma patients
by: Ahmed A.E Hassan Desoky, et al.
Published: (2019-01-01)

Repeated transcatheter arterial chemoembolization is safe for hepatocellular carcinoma in cirrhotic patients with transjugular intrahepatic portosystemic shunt
by: Zhu Wang, et al.
Published: (2014-11-01)

Efficacy of Postoperative Adjuvant Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma Patients With Microscopic Portal Vein Invasion
by: Yiwen Qiu, et al.
Published: (2022-06-01)

A Nomogram Based on Preoperative Lipiodol Deposition after Sequential Retreatment with Transarterial Chemoembolization to Predict Prognoses for Intermediate-Stage Hepatocellular Carcinoma
by: Xiang-Ke Niu, et al.
Published: (2022-08-01)

Child–Pugh grade deterioration stratified by the etiology after transcatheter arterial chemoembolization as initial treatment for hepatocellular carcinoma
by: Kengo Yoshitomi, et al.
Published: (2024-02-01)

Clinical Effect of Lenvatinib Re-Administration after Transcatheter Arterial Chemoembolization in Patients with Intermediate Stage Hepatocellular Carcinoma
by: Seiichi Mawatari, et al.
Published: (2022-12-01)

Prognostic Significance of Tumor Growth Rate (TGR) in Patients with Huge Hepatocellular Carcinoma Undergoing Transcatheter Arterial Chemoembolization
by: Guobin Chen, et al.
Published: (2022-01-01)

Comparison of surgical resection and transcatheter arterial chemoembolization for large hepatocellular carcinoma: a systematic review and meta-analysis
by: Luke Zhou, et al.
Published: (2023-03-01)

Lipiodol Embolism with Pneumonitis and ALI after TACE – A Case Report
by: Devendrappa K R, et al.
Published: (2023-07-01)

Added Value of Cone-Beam Computed Tomography for Detecting Hepatocellular Carcinomas and Feeding Arteries during Transcatheter Arterial Chemoembolization Focusing on Radiation Exposure
by: Duk-Ju Kim, et al.
Published: (2023-06-01)

Initial Transarterial Chemoembolization (TACE) Using HepaSpheres 20–40 µm and Subsequent Lipiodol TACE in Patients with Hepatocellular Carcinoma > 5 cm
by: Su Min Cho, et al.
Published: (2021-04-01)

Retracted: Effect of Transcatheter Arterial Chemoembolization Combined with Radiofrequency Ablation on Liver Function and Immune Function in Patients with Hepatocellular Carcinoma
by: Emergency Medicine International
Published: (2024-01-01)

PNI-Based Nomograms to Predict Tumor Progression and Survival for Patients with Unresectable Hepatocellular Carcinoma Undergoing Transcatheter Arterial Chemoembolization
by: Kai Lei, et al.
Published: (2023-01-01)

Identification of Potential Predictors of Prognosis and Sorafenib-Associated Survival Benefits in Patients with Hepatocellular Carcinoma after Transcatheter Arterial Chemoembolization
by: Kun He, et al.
Published: (2022-12-01)

Preoperative transcatheter arterial chemoembolization and prognosis of patients with solitary large hepatocellular carcinomas (≥5 cm): Multicenter retrospective study
by: Ali Mo, et al.
Published: (2023-04-01)

Agitated saline sonography: a simple technique for intraprocedural feeder identification during transcatheter arterial chemoembolization of hepatocellular carcinoma
by: B. P. Krishna Prasad, et al.
Published: (2016-05-01)

Percutaneous thermal ablation combined with transcatheter arterial chemoembolization for hepatitis C virus-related hepatocellular carcinoma: Efficacy and survival
by: Yu Sun, et al.
Published: (2022-09-01)

Relationship between M6A methylation regulator and prognosis in patients with hepatocellular carcinoma after transcatheter arterial chemoembolization
by: Deliang Huang, et al.
Published: (2022-10-01)

Transarterial Bleomycin–Lipiodol Chemoembolization for the Treatment of Giant Hepatic Hemangiomas: An Assessment of Effectiveness
by: Arkadiusz Kacała, et al.
Published: (2024-01-01)

A Hypoxia-Related miRNA-mRNA Signature for Predicting the Response and Prognosis of Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma
by: Zong S, et al.
Published: (2024-03-01)

Benefits of step-by-step debulking microwave ablation for huge unresectable hepatocellular carcinoma patients after transcatheter arterial chemoembolization refractoriness
by: Tao Huang, et al.
Published: (2022-12-01)

Transcatheter hepatic arterial chemoembolization in cirrhotic patients with hepatocellular carcinoma before liver transplantation: the prognostic value of alpha-fetoprotein concentrations
by: D. A. Granov, et al.
Published: (2021-01-01)

Hepatic Arterial Infusion Chemotherapy vs Transcatheter Arterial Chemoembolization as Adjuvant Therapy Following Surgery for MVI-Positive Hepatocellular Carcinoma: A Multicenter Propensity Score Matching Analysis
by: Wen Y, et al.
Published: (2024-04-01)

Proteoglycan-4 predicts good prognosis in patients with hepatocellular carcinoma receiving transcatheter arterial chemoembolization and inhibits cancer cell migration in vitro
by: Yuan Guo, et al.
Published: (2022-11-01)

Hepatic Arterial Infusion Chemotherapy Followed by Lipiodol Infusion for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Single-Center Experience
by: Kuan-Ting Chen, et al.
Published: (2021-07-01)

Lipiodol-induced Pneumonitis Following Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma

Similar Items

Similar Items